Brinker Capital’s DexCom DXCM Stock Holding History

Brinker Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-48,784	Closed	-$892K	–	946
2017 Q2	$892K	Buy	48,784 +10,048	+26%	+$186K	0.04%	392
2017 Q1	$821K	Sell	38,736 -3,892	-9%	-$76K	0.04%	430
2016 Q4	$636K	Buy	+42,628	New	+$755K	0.04%	391

Other funds holding DXCM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Brinker Capital's DXCM Position: Q3 2017 in Review

Brinker Capital sold out of DexCom (DXCM) in Q3 2017, closing a stake of 48,784 shares — an estimated $892K sold.

Brinker Capital first reported a position in DXCM in Q4 2016 and held it in 3 quarters. The position peaked at $892K in Q2 2017. 275 funds tracked by Wall St. Rank hold DXCM as of Q3 2017.

Brinker Capital reported no remaining DexCom position as of Q3 2017 after selling out during the quarter.
Brinker Capital sold 48,784 DexCom shares in Q3 2017, an estimated $892K.
Brinker Capital first reported a position in DexCom in Q4 2016 and held it in 3 quarters.
Brinker Capital's DexCom position peaked at $892K in Q2 2017.
275 funds tracked by Wall St. Rank held DexCom as of Q3 2017.

Based on Brinker Capital's 13F filing for Q3 2017, filed 14 Nov 2017.